Literature DB >> 12898644

Influence of culture time on the expression of drug-metabolizing enzymes in primary human hepatocytes and hepatoma cell line HepG2.

Stefan Wilkening1, Augustinus Bader.   

Abstract

Primary cultures of human hepatocytes and hepatoma cell line HepG2 are frequently used to evaluate the hepatic disposition of drugs and other xenobiotics. To check the variability of the expression of drug-metabolizing enzymes in these in vitro models, expression of genes coding for several cytochrome P450 isoforms and phase II enzymes was quantified during culture time by real-time RT-PCR. Gene expression was determined daily for primary hepatocytes maintained in a sandwich culture over 1 week and for HepG2, during the first 10 passages. In primary hepatocytes characteristic expression trends were observed which could be abstracted into three major classes of time curves. Genes of the first and the second class had an expression maximum around day 6 and day 4 in culture, respectively. The third class of genes had two expression peaks: at day 1 and 5 in culture. Surprisingly, also the cell line HepG2 showed significant expression changes during passages. For example, gene expression of cytochrome 1A1 varied 8-fold, that of cytochrome 2B6 30-fold, and that of NADP-quinone reductase 1 more than 200-fold within the first 10 passages. In conclusion, neither primary hepatocytes nor HepG2 cell line display a model for constant expression of drug-metabolizing enzymes. Copyright 2003 Wiley Periodicals, Inc. J Biochem Mol Toxicol 17:207-213, 2003; Published online in Wiley InterScience (www.interscience.wiley.com). DOI 10.1002/jbt.10085

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12898644     DOI: 10.1002/jbt.10085

Source DB:  PubMed          Journal:  J Biochem Mol Toxicol        ISSN: 1095-6670            Impact factor:   3.642


  19 in total

1.  Endosulfan upregulates AP-1 binding and ARE-mediated transcription via ERK1/2 and p38 activation in HepG2 cells.

Authors:  Min Ok Song; Chang-Ho Lee; Hyun Ok Yang; Jonathan H Freedman
Journal:  Toxicology       Date:  2011-11-28       Impact factor: 4.221

2.  In vitro characterization of the human biotransformation pathways of aplidine, a novel marine anti-cancer drug.

Authors:  Esther F A Brandon; Rolf W Sparidans; Ronald D van Ooijen; Irma Meijerman; Luis Lopez Lazaro; Ignacio Manzanares; Jos H Beijnen; Jan H M Schellens
Journal:  Invest New Drugs       Date:  2007-02       Impact factor: 3.850

3.  A novel 3D liver organoid system for elucidation of hepatic glucose metabolism.

Authors:  Yanhua Lu; Guoliang Zhang; Chong Shen; Korkut Uygun; Martin L Yarmush; Qin Meng
Journal:  Biotechnol Bioeng       Date:  2011-10-19       Impact factor: 4.530

4.  Infliximab exerts no direct hepatotoxic effect on HepG2 cells in vitro.

Authors:  Hilbert S de Vries; Tineke de Heij; Henie M J Roelofs; Rene H M te Morsche; Wilbert H M Peters; Dirk J de Jong
Journal:  Dig Dis Sci       Date:  2012-04-26       Impact factor: 3.199

5.  Synergetic effects of DNA demethylation and histone deacetylase inhibition in primary rat hepatocytes.

Authors:  Joanna Edyta Fraczek; Mathieu Vinken; Dirk Tourwé; Tamara Vanhaecke; Vera Rogiers
Journal:  Invest New Drugs       Date:  2011-03-29       Impact factor: 3.850

6.  Aryl hydrocarbon receptor and NF-E2-related factor 2 are key regulators of human MRP4 expression.

Authors:  Shuhua Xu; Jittima Weerachayaphorn; Shi-Ying Cai; Carol J Soroka; James L Boyer
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2010-04-15       Impact factor: 4.052

7.  Rifampicin exacerbates isoniazid-induced toxicity in human but not in rat hepatocytes in tissue-like cultures.

Authors:  C Shen; Q Meng; G Zhang; W Hu
Journal:  Br J Pharmacol       Date:  2007-12-10       Impact factor: 8.739

Review 8.  HBV culture and infectious systems.

Authors:  C Nelson Hayes; Kazuaki Chayama
Journal:  Hepatol Int       Date:  2016-03-02       Impact factor: 6.047

9.  Building shared experience to advance practical application of pathway-based toxicology: liver toxicity mode-of-action.

Authors:  Catherine Willett; Jessica Caverly Rae; Katy O Goyak; Gary Minsavage; Carl Westmoreland; Melvin Andersen; Mark Avigan; Daniel Duché; Georgina Harris; Thomas Hartung; Hartmut Jaeschke; Andre Kleensang; Brigitte Landesmann; Suzanne Martos; Marilyn Matevia; Colleen Toole; Andrew Rowan; Terry Schultz; Jennifer Seed; John Senior; Imran Shah; Kalyanasundaram Subramanian; Mathieu Vinken; Paul Watkins
Journal:  ALTEX       Date:  2014-01-28       Impact factor: 6.043

10.  Screening for drug-induced hepatotoxicity in primary mouse hepatocytes using acetaminophen, amiodarone, and cyclosporin a as model compounds: an omics-guided approach.

Authors:  Anke Van Summeren; Johan Renes; Daneida Lizarraga; Freek G Bouwman; Jean-Paul Noben; Joost H M van Delft; Jos C S Kleinjans; Edwin C M Mariman
Journal:  OMICS       Date:  2013-01-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.